Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-014-2560-3
Published Online: 2014-08-14
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Garg, Amit
Quartino, Angelica
Li, Jing
Jin, Jin
Wada, D. Russell
Li, Hanbin
Cortés, Javier
McNally, Virginia
Ross, Graham
Visich, Jennifer
Lum, Bert
Text and Data Mining valid from 2014-08-14